Puretech Health Plc (PRTC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 112,077 | 1,723 | -1,294 | -783 | -395 |
| Accounts receivable | 747 | 467 | -1,672 | 581 | 1,112 |
| Other Working Capital | 15,028 | 9,964 | 2,969 | 1,935 | 4,807 |
| Other Operating Activity | -226,008 | -84,950 | -88,691 | -59,766 | -34,135 |
| Operating Cash Flow | $-98,156 | $-72,796 | $-88,688 | $-58,033 | $-28,611 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,947 | -4,240 | -2,091 | -3,676 | -3,455 |
| Net Acquisitions | -29,706 | -13,390 | -16,340 | N/A | N/A |
| Purchase Of Investment | -77,577 | -169,952 | -147,203 | -312,825 | -385,383 |
| Sale Of Investment | 183,289 | 148,062 | 249,396 | 273,270 | 205,752 |
| Purchase Sale Intangibles | -400 | -125 | -80 | 0 | -1,155 |
| Investing Cash Flow | $63,659 | $-39,645 | $83,682 | $-43,231 | $-184,241 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 0 | 268 | 0 |
| Debt Issued | 1,606 | 6,147 | 2,616 | 2,060 | 1,845 |
| Debt Repayment | -178 | -185 | -163 | 0 | -366 |
| Common Stock Issued | 50,272 | 152,030 | 12,400 | 27,260 | 235,656 |
| Common Stock Repurchased | 0 | -35 | -66 | N/A | N/A |
| Dividend Paid | -112 | -1,070 | -91 | N/A | N/A |
| Other Financing Activity | -1,678 | 0 | 0 | -100 | 48,802 |
| Financing Cash Flow | $49,910 | $156,887 | $14,696 | $29,488 | $285,937 |
| Exchange Rate Effect | -104 | -44 | 0 | -16 | -294 |
| Beginning Cash Position | 117,051 | 72,649 | 62,959 | 134,751 | 61,960 |
| End Cash Position | 132,360 | 117,051 | 72,649 | 62,959 | 134,751 |
| Net Cash Flow | $15,413 | $44,446 | $9,690 | $-71,776 | $73,085 |
| Free Cash Flow | |||||
| Operating Cash Flow | -98,156 | -72,796 | -88,688 | -58,033 | -28,611 |
| Capital Expenditure | -12,538 | -4,490 | -2,171 | -3,676 | -4,610 |
| Free Cash Flow | -110,694 | -77,286 | -90,859 | -61,709 | -33,221 |